Medy-Tox (XKRX:086900) EV-to-Revenue : 4.35 (As of May. 15, 2024)

Medy-Tox EV-to-Revenue Chart

Medy-Tox Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					8.31	7.56	4.79	4.47	7.58

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															4.47	7.65	8.13	8.51	7.58

Competitive Comparison of Medy-Tox's EV-to-Revenue

For the Biotechnology subindustry, Medy-Tox's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medy-Tox's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medy-Tox's EV-to-Revenue falls into.

Medy-Tox EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medy-Tox's EV-to-Revenue for today is calculated as:

Medy-Tox's current Enterprise Value is ₩961,796 Mil.
Medy-Tox's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩221,121 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medy-Tox  (XKRX:086900) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medy-Tox's PS Ratiofor today is calculated as:

Medy-Tox's share price for today is ₩135500.00.
Medy-Tox's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩32,290.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medy-Tox EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medy-Tox's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description